Xtx Topco LTD Bridge Bio Pharma, Inc. Transaction History

Xtx Topco LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$23.0 - $31.04 $102,580 - $138,438	-4,460 Reduced 26.94%	12,096 $306,000
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $281,103 - $415,745	10,278 Added 163.71%	16,556 $511,000
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $150,797 - $275,541	6,278 New	6,278 $253,000
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $269,095 - $364,666	20,248 New	20,248 $348,000
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $205,691 - $351,567	-30,518 Reduced 45.23%	36,952 $281,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $535,711 - $833,929	67,470 New	67,470 $671,000
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $78,415 - $182,719	-15,051 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.34 - $17.16 $110,474 - $258,275	15,051 New	15,051 $153,000
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $81,640 - $383,163	-7,174 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $336,245 - $460,857	7,174 New	7,174 $336,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.